Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 19.15 is 37% above its 5-year average of 13.93, around the middle of its 5-year range (3.49–31.15).
As of the fiscal period ended Tuesday, June 30, 2026. 17.99% above its 12-month average of 16.23.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.15.
CURRENT RATIO
19.15
CURRENT RATIO AVG TTM
16.23
CURRENT RATIO AVG 3Y
9.46
CURRENT RATIO AVG 5Y
13.93
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.99%
CURRENT VS 3Y AVG
+102.39%
CURRENT VS 5Y AVG
+37.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+410.58%
vs the sector median at left
Market Cap
$996.18M
Current Ratio
6.55
TTM Avg
7.96
3Y Avg
7.82
5Y Avg
9.82
Market Cap
$1.00B
Current Ratio
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$979.16M
Current Ratio
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$969.38M
Current Ratio
5.04
TTM Avg
3.47
3Y Avg
3.89
5Y Avg
3.30
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vor Biopharma Inc. (VOR) | $994.31M | 19.15 | 16.23 | 9.46 | 13.93 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.18M | 6.55 | 7.96 | 7.82 | 9.82 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.00B | 8.42 | 11.89 | 15.48 | 17.00 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $979.59M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.16M | 15.08 | 22.50 | 27.08 | 27.08 |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
| MeiraGTx Holdings plc (MGTX)vs › | $977.49M | 3.76 | 1.39 | 1.76 | 2.46 |
| Pacira BioSciences, Inc. (PCRX)vs › | $969.38M | 5.04 | 3.47 | 3.89 | 3.30 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | 6.04 | 6.28 | 6.71 | 10.27 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | 16.35 | 49.13 | 36.30 | 29.95 |
Current Ratio
19.15
Quick Ratio
19.15
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 19.15 |
| 2026-03-31 | 31.15 |
| 2025-12-31 | 18.20 |
| 2025-09-30 | 9.16 |
| 2025-06-30 | 3.49 |
| 2025-03-31 | 3.88 |
| 2024-12-31 | 5.19 |
| 2024-09-30 | 4.69 |
| 2024-06-30 | 6.54 |
| 2024-03-31 | 8.46 |
| 2023-12-31 | 9.04 |
| 2023-09-30 | 10.69 |
| 2023-06-30 | 15.05 |
| 2023-03-31 | 17.24 |
| 2022-12-31 | 18.06 |
| 2022-09-30 | 12.86 |
| 2022-06-30 | 12.95 |
| 2022-03-31 | 10.49 |
| 2021-12-31 | 21.12 |
| 2021-09-30 | 25.20 |
| 2021-06-30 | 30.02 |
| 2021-03-31 | 30.85 |
| 2020-12-31 | 4.81 |
| 2020-09-30 | 8.62 |
| 2020-06-30 | 18.96 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 3.45 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
